nach oben

Erschienen in:

Open Access 08.06.2020 | COVID-19 | Letter

Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial

verfasst von: Nooshin Dalili, Alireza Kashefizadeh, Mohsen Nafar, Fatemeh Poorrezagholi, Ahmad Firouzan, Fariba Samadian, Shiva Samavat, Shadi Ziaie, Somayeh Fatemizadeh

Erschienen in: Trials | Ausgabe 1/2020

Titel: Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial
verfasst von: Nooshin Dalili
Alireza Kashefizadeh
Mohsen Nafar
Fatemeh Poorrezagholi
Ahmad Firouzan
Fariba Samadian
Shiva Samavat
Shadi Ziaie
Somayeh Fatemizadeh
Publikationsdatum: 08.06.2020
Verlag: BioMed Central
Schlagwort: COVID-19
Erschienen in: Trials / Ausgabe 1/2020
Elektronische ISSN: 1745-6215
DOI: https://doi.org/10.1186/s13063-020-04455-3

Springer Medizin

Weitere Artikel der Ausgabe 1/2020

A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: protocol and rationale of the Take a STAND for Health study

PALLiON – PALLiative care Integrated in ONcology: study protocol for a Norwegian national cluster-randomized control trial with a complex intervention of early integration of palliative care

Update of the ULtra-early TRranexamic Acid after Subarachnoid Hemorrhage (ULTRA) trial: statistical analysis plan

Vitamin D for prevention of sternotomy healing complications: REINFORCE-D trial

Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial

Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial